Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis
- 1 January 2001
- journal article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 31 (1), 61-68
- https://doi.org/10.1046/j.1365-2222.2001.00964.x
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flowClinical & Experimental Allergy, 2000
- The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthmaClinical & Experimental Allergy, 1999
- Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitisJournal of Allergy and Clinical Immunology, 1998
- Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unitJournal of Allergy and Clinical Immunology, 1998
- The naso-oral index: a more valid measure than peak flow rate?Clinical Otolaryngology, 1997
- Measuring the systemic effects of inhaled beclomethasone: timed morning urine collections compared with 24 hour specimens.Thorax, 1995
- Soluble markers of allergic inflammationAllergy, 1994
- Glucocorticosteroids and rhinitisAllergy, 1993
- Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretion in humansClinical & Experimental Allergy, 1986